The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
This application is a continuation application of U.S. Ser. No. 09/762,302, filed Feb. 8, 2001, now U.S. Pat. No. 7,041,313, which was filed under 35 U.S.C. 371 as a national stage of PCT/EP99/05724, filed Aug. 7, 1999.
